These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 8814

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Correlation between plasma levels of prolactin and chlorpromazine in psychiatric patients.
    Kolakowska T, Wiles DH, McNeilly AS, Gelder MG.
    Psychol Med; 1975 May; 5(2):214-6. PubMed ID: 240179
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical significance of plasma drug and prolactin levels during acute chlorpromazine treatment: a replication study.
    Kolakowska T, Orr M, Gelder M, Heggie M, Wiles D, Franklin M.
    Br J Psychiatry; 1979 Oct; 135():352-9. PubMed ID: 519119
    [Abstract] [Full Text] [Related]

  • 5. Relationships between drug concentrations in serum and CSF, clinical effects and monoaminergic variables in schizophrenic patients treated with sulpiride or chlorpromazine.
    Alfredsson G, Bjerkenstedt L, Edman G, Härnryd C, Oxenstierna G, Sedvall G, Wiesel FA.
    Acta Psychiatr Scand Suppl; 1984 Oct; 311():49-74. PubMed ID: 6199949
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of a drug holiday on plasma chlorpromazine levels in chronic schizophrenic patients.
    Hershey LA, Gift T, Atkins RW, Rivera-Calimlim L.
    Psychopharmacology (Berl); 1981 Oct; 73(4):355-8. PubMed ID: 6789357
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of antimalarial agents on plasma levels of chlorpromazine and its metabolites in schizophrenic patients.
    Makanjuola RO, Dixon PA, Oforah E.
    Trop Geogr Med; 1988 Jan; 40(1):31-3. PubMed ID: 3381314
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dehalogenation and N-dealkylation of chlorpromazine as revealed by plasma concentrations of metabolites in a population of chronically medicated schizophrenics.
    Valoti M, Palmi M, Della Corte L, Nardini M, Corti P, Sgaragli GP.
    Methods Find Exp Clin Pharmacol; 1992 Jan; 14(6):445-50. PubMed ID: 1469953
    [Abstract] [Full Text] [Related]

  • 13. The use of a side effect as a qualitative indicator of plasma chlorpromazine levels.
    Chetty M, Gouws E, Miller R, Moodley SV.
    Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):77-82. PubMed ID: 10082231
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Serum prolactin response to chlorpromazine and psychopathology in schizophrenics: implications for the dopamine hypothesis.
    Meltzer HY, Busch D.
    Psychiatry Res; 1983 Aug; 9(4):285-99. PubMed ID: 6580661
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.